Satsuma Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Satsuma Pharmaceuticals generated cash of -$51,516,000, which is less than the previous year. Cash used in financing activities reached the amount of $8,739,000 last year. Net change in cash is therefore $594,000.
Cash Flow
| 2017 | -4.32M | -58K | 0 |
|---|---|---|---|
| 2018 | -6.98M | -402K | 10.93M |
| 2019 | -29.63M | -95.87M | 143.06M |
| 2020 | -42.32M | 57.99M | -2.10M |
| 2021 | -42.99M | -50.77M | 73.28M |
| 2022 | -51.51M | 43.37M | 8.73M |
STSA Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 15.83M | 36.32M | 22.75M | 5.20M | 1.65M | 6.03M |
Operating activities | ||||||
Net income | -70.05M | -51.17M | -47.56M | -28.17M | -7.34M | -5.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 683K | 393K | 239K | 141K | 57K | 10K |
Stock-based compensation expense | 5.70M | 5.36M | 4.01M | 747K | 170K | 66K |
| Deferred income tax benefit | 5.70M | 5.36M | 4.01M | 747K | 170K | 66K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 466K | -1.21M | -1.62M | 3.98M | -177K | 363K |
Cash generated by operating activities | -51.51M | -42.99M | -42.32M | -29.63M | -6.98M | -4.32M |
Investing activities | ||||||
Purchases Of Investments | -47.77M | -88.62M | -34.00M | -99.85M | 0 | 0 |
Investments In Property Plant And Equipment | -472K | -2.03M | -5.16M | -551K | -402K | -58K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 43.37M | -50.77M | 57.99M | -95.87M | -402K | -58K |
Financing activities | ||||||
Common Stock Issued | 9.7M | 75.21M | 134K | 81.43M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2M | -2M | 0 | 0 | 0 |
Cash used in financing activities | 8.73M | 73.28M | -2.10M | 143.06M | 10.93M | 0 |
Net Change In Cash | 594K | -20.49M | 13.57M | 17.55M | 3.54M | -4.37M |
Cash at end of period | 16.42M | 15.83M | 36.32M | 22.75M | 5.20M | 1.65M |
| Data source | Data source | Data source | Data source |